Literature DB >> 3977598

Predicative calculation of the efficiency of hemodialysis or hemoperfusion for the removal of drugs from the body.

H H Wellhöner.   

Abstract

Formula are derived for the calculation of the amounts of drug which, during a defined time interval, are eliminated from the body with and without the help of hemodialysis or hemoperfusion (HD/HP). A programmable pocket calculator like the TI-59 suffices to perform all calculations. The pharmacokinetic system constants of the drug, the effective plasma flow, and the HD/HP plasma extraction rate are entered into the program. Additional information can be obtained if the plasma concentration of the drug at the onset of HD/HP is known. Worked examples are presented.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3977598     DOI: 10.1007/bf00333424

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  18 in total

1.  Plasma and erythrocyte levels of tricyclic antidepressants in depressed patients.

Authors:  M Linnoila; F Dorrity; K Jobson
Journal:  Am J Psychiatry       Date:  1978-05       Impact factor: 18.112

2.  Kinetic modeling of hemodialysis, hemofiltration, and hemodiafiltration.

Authors:  K B Sprenger; W Kratz; A E Lewis; U Stadtmüller
Journal:  Kidney Int       Date:  1983-08       Impact factor: 10.612

3.  Blood/plasma distribution ratios of psychotropic drugs.

Authors:  K P Maguire; G D Burrows; T R Norman; B A Scoggins
Journal:  Clin Chem       Date:  1980-10       Impact factor: 8.327

4.  Plasma protein binding and distribution characteristics of drugs as indices of their hemodialyzability.

Authors:  P R Gwilt; D Perrier
Journal:  Clin Pharmacol Ther       Date:  1978-08       Impact factor: 6.875

5.  Patient-hemodialyzer interactions.

Authors:  K Schindhelm; P C Farrell
Journal:  Trans Am Soc Artif Intern Organs       Date:  1978

6.  Clinical pharmacologic observations on atenolol, a beta-adrenoceptor blocker.

Authors:  H C Brown; S G Carruthers; G D Johnston; J G Kelly; J McAinsh; D G McDevitt; R G Shanks
Journal:  Clin Pharmacol Ther       Date:  1976-11       Impact factor: 6.875

7.  Clearance and recovery calculations in hemodialysis: application to plasma, red blood cells, and dialysate measurements for cyclophosphamide.

Authors:  L H Wang; C S Lee; B L Majeske; T C Marbury
Journal:  Clin Pharmacol Ther       Date:  1981-03       Impact factor: 6.875

8.  Pharmacokinetics of amitriptyline infused intravenously in man.

Authors:  A Jorgensen; V Hansen
Journal:  Eur J Clin Pharmacol       Date:  1976-09-30       Impact factor: 2.953

9.  Pharmacokinetics of atenolol in patients with terminal renal failure and influence of haemodialysis.

Authors:  B Flouvat; S Decourt; P Aubert; L Potaux; M Domart; A Goupil; A Baglin
Journal:  Br J Clin Pharmacol       Date:  1980-04       Impact factor: 4.335

Review 10.  Drug therapy in patients undergoing haemodialysis. Clinical pharmacokinetic considerations.

Authors:  C S Lee; T C Marbury
Journal:  Clin Pharmacokinet       Date:  1984 Jan-Feb       Impact factor: 6.447

View more
  2 in total

Review 1.  Clinical pharmacokinetics of ethanol.

Authors:  N H Holford
Journal:  Clin Pharmacokinet       Date:  1987-11       Impact factor: 6.447

2.  Toxicokinetics of labeled amatoxins in the dog.

Authors:  H Faulstich; A Talas; H H Wellhöner
Journal:  Arch Toxicol       Date:  1985-01       Impact factor: 5.153

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.